[Disclosure] Jeju Semiconductor (080220) – (Correction) Decision on Issuance of Convertible Bonds (8th Series) / 2025-02-24
[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Application for CT-P13 SC (Remsima Subcutaneous) in Pediatric Ulcerative Colitis in Korea / 2025-02-24